1 |
Multiple newly identified loci associated with prostate cancer susceptibility.
8
|
Eeles RA...Easton DF
|
18264097
|
2008 |
2 |
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.
8
|
Friedrichsen DM...Xu J
|
14769943
|
2004 |
3 |
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017.
38
|
Saad M...Ong TA
|
31077523
|
2019 |
4 |
Experimental 177Lu-PSMA-617 radioligand therapy in a patient with extended metastasized leiomyosarcoma.
38
|
Juptner M...Lutzen U
|
31140181
|
2019 |
5 |
Characterization of the Recommendations in the Choosing Wisely Initiative.
38
|
Corrigan K...Kamal A
|
30345804
|
2019 |
6 |
Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
38
|
Giganti F...Kirkham A
|
29135073
|
2018 |
7 |
Gambogic Acid Induces Cell Apoptosis and Inhibits MAPK Pathway in PTEN-/-/p53-/- Prostate Cancer Cells In Vitro and Ex Vivo.
38
|
Pan H...Lin HS
|
28578487
|
2018 |
8 |
The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
38
|
Nafie S...Khan M
|
28299763
|
2017 |
9 |
Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.
38
|
Zhao J...Lu J
|
28039477
|
2017 |
10 |
Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.
38
|
Zhang J...Chen X
|
27493267
|
2017 |
11 |
Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
38
|
Shetty D...Do V
|
27556788
|
2016 |
12 |
Simultaneous PET/MRI vs PET/CT in oncology. A systematic review.
38
|
Riola-Parada C...Carreras-Delgado JL
|
27424217
|
2016 |
13 |
[Mechanisms of castration resistance: Intratumoral hypoxia stimulates the androgen receptor expression].
38
|
Lunardi P...Malavaud B
|
26896427
|
2016 |
14 |
Lung Cancer and Multiple Neoplasms: A Retrospective Analysis.
38
|
Romaszko A...Luks J
|
26987325
|
2016 |
15 |
Prostate cancer: 4 big questions.
38
|
Hodson R
|
26672789
|
2015 |
16 |
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with sex hormone depletion treatment].
38
|
Takahashi S
|
26320536
|
2015 |
17 |
Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.
38
|
Zhu Y...Xie L
|
25351792
|
2015 |
18 |
The epidemiology of cancer in Angola-results from the cancer registry of the national oncology centre of Luanda, Angola.
38
|
Armando A...Miguel F
|
25729423
|
2015 |
19 |
Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies.
38
|
Schwingshackl L...Hoffmann G
|
24599882
|
2014 |
20 |
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.
38
|
Lane JA...ProtecT study group
|
25163905
|
2014 |
21 |
Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.
38
|
Reis BS...Gnjatic S
|
24081977
|
2013 |
22 |
Genetic testing in the European Union: does economic evaluation matter?
38
|
Antonanzas F...Pinillos M
|
21598012
|
2012 |
23 |
Stomach metastasis in a patient with prostate cancer 4 years after the initial diagnosis: a case report and a literature review.
38
|
Bilici A...Selcukbiricik F
|
23243531
|
2012 |
24 |
Overdiagnosis of a typical carcinoid tumor as an adenocarcinoma of the lung: a case report and review of the literature.
38
|
Demirci I...Jan?en H
|
22269186
|
2012 |
25 |
Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
38
|
Medical Advisory Secretariat
|
23074405
|
2010 |
26 |
Effects of interval between diagnosis and time of survey upon preferred information format for prostate cancer patients.
38
|
Sharpley CF...Christie DR
|
19527371
|
2009 |
27 |
Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
38
|
Schroder FH...Fleshner N
|
19012915
|
2009 |
28 |
[Antioxidant power and cellular damage in prostate cancer].
38
|
Lopez Laur JD...Ortiz A
|
18709810
|
2008 |
29 |
What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?
38
|
Monahan PO...Koch M
|
17091363
|
2007 |
30 |
Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
38
|
Montgomery EA...Epstein JI
|
17122505
|
2006 |
31 |
Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
38
|
Parwani AV...Epstein JI
|
17001156
|
2006 |
32 |
Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made.
38
|
Clark JA...Talcott JA
|
16983114
|
2006 |
33 |
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
38
|
Kobayashi N...Aronson WJ
|
16899616
|
2006 |
34 |
Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy.
38
|
Kelavkar UP...McHugh K
|
16611404
|
2006 |
35 |
Therapeutic targeting of prostate cancer.
38
|
Cress AE...Mohla S
|
15539935
|
2004 |
36 |
Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence.
38
|
Ngo TH...Aronson WJ
|
14973081
|
2004 |
37 |
Ethnic differences in quality of life among early breast and prostate cancer survivors.
38
|
Gotay CC...Pagano I
|
11921326
|
2002 |
38 |
Changes in natural killer cell activity by external radiotherapy and/or brachytherapy.
38
|
Yamazaki H...Inoue T
|
11836608
|
2002 |
39 |
[Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
38
|
Perdona S...D'Armiento M
|
11221051
|
2000 |
40 |
[RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
38
|
Okubo Y...Ito T
|
10086262
|
1999 |
41 |
Prostate cancer: 4. Screening.
38
|
Meyer F...Fradet Y
|
9834724
|
1998 |
42 |
Insulin-like growth factors and prostate cancer.
38
|
Pollak M...Zhang JC
|
10453282
|
1998 |
43 |
[Study on the quality of life in patients with prostate cancer].
38
|
Du SF...Zhang HJ
|
9812508
|
1997 |
44 |
Cancer mortality among pulp and paper workers in Poland. A cohort study.
38
|
Szadkowska-Stanczyk I...Szymczak W
|
9187043
|
1997 |
45 |
Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate.
38
|
Carter HB...Epstein JI
|
9436285
|
1997 |
46 |
Combined finasteride and flutamide therapy in men with advanced prostate cancer.
38
|
Ornstein DK...Andriole GL
|
8973674
|
1996 |
47 |
[Screening of cancer of the prostate: study in a Spanish population].
38
|
Herrero Payo JA...Berenguer Sanchez A
|
8929102
|
1996 |
48 |
Update on urology--prostate cancer. 4--Treatment of local disease.
38
|
Bowsher WG
|
8631420
|
1995 |
49 |
[Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
38
|
Shinoda I...Tada K
|
1927771
|
1991 |
50 |
Ultrasound of the prostate--applications and indications.
38
|
Rifkin MD
|
2024104
|
1991 |